Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.29% | -35.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.29% | -35.50% | |||
| Operating Income | 14.29% | 35.50% | |||
| Income Before Tax | -8.06% | 30.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.06% | 30.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.06% | 30.14% | |||
| EBIT | 14.29% | 35.50% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -6.98% | 57.19% | |||
| Normalized Basic EPS | -6.74% | 57.13% | |||
| EPS Diluted | -6.98% | 57.83% | |||
| Normalized Diluted EPS | -6.74% | 57.13% | |||
| Average Basic Shares Outstanding | 1.11% | 63.12% | |||
| Average Diluted Shares Outstanding | 1.11% | 63.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||